- In January 2025, Bayer Consumer Health entered the U.K. menopause market with CanesMeno, offering a comprehensive range of scientifically-supported products along with a digital education resource to assist around 13 million perimenopausal and menopausal women in managing their symptoms effectively. This launch strengthens Bayer’s footprint in the women’s health segment in Europe
- In April 2025, Tranont unveiled a new series of women’s health supplements focused on enhancing muscle strength, energy, and hormonal balance. The product line includes a menopause-supporting formula containing EstroG-100 and ashwagandha, a digestion-friendly clear whey protein, and a creatine supplement tailored for women over 30 experiencing age-related muscle decline. This expansion reinforces Tranont’s commitment to holistic women’s wellness
- In January 2025, GNC introduced Premier Collagen, a beauty supplement line with two specialized formulas in multiple formats, designed to promote youthful-looking skin and overall beauty from within. This initiative marks GNC’s expansion into the growing beauty-from-within nutraceuticals market
- In September 2024, Otsuka Pharmaceutical Co., Ltd. and Bonafide Health, LLC jointly launched Thermella in the U.S., a plant-based supplement created to support women’s health during menopause, available exclusively through Bonafide Health’s digital platform. This collaboration underscores both companies’ dedication to addressing hormonal health naturally
- In October 2020, Oziva launched HerBones, a 100% plant-based and vegan supplement formulated to support stronger bones, healthy joints, and balanced female hormones. Designed for women aged 25 and above, particularly those with calcium deficiency, this product reinforced Oziva’s focus on preventive women’s health solutions
